Comments
Loading...
bluebird bio (BLUE) Forecast
NewsEarningsbluebird bio (BLUE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interestbluebird bio (NASDAQ:BLUE) Stock Quotes, Forecast and News Summary
bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy bluebird bio (BLUE) stock?
You can purchase shares of bluebird bio (NASDAQ:BLUE) through any online brokerage.
Who are bluebird bio (BLUE) competitors?
Other companies in bluebird bio’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Monopar Therapeutics (NASDAQ:MNPR), Aligos Therapeutics (NASDAQ:ALGS) and Citius Oncology (NASDAQ:CTOR).
What is the forecast, or price target, for bluebird bio (BLUE) stock?
bluebird bio has a consensus price target of $4.27.
What is the current price for bluebird bio (BLUE)?
The stock price for bluebird bio (NASDAQ: BLUE) is $0.3267 last updated November 15, 2024 at 11:56 AM EST.
Does bluebird bio (BLUE) pay a dividend?
There are no upcoming dividends for bluebird bio.
When is bluebird bio (NASDAQ:BLUE) reporting earnings?
bluebird bio’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is bluebird bio (BLUE) going to split?
There is no upcoming split for bluebird bio.
What sector and industry does bluebird bio (BLUE) operate in?
bluebird bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.